Carlos Martin

Chief Commercial Officer at Neurvati Neurosciences, a Blackstone company

Speaker

Carlos Martin is Chief Commercial Officer at Neurvati Neurosciences, where he leads the company’s evolution from a development-stage organization to a fully integrated commercial neuroscience group focused on delivering transformative therapies for patients with rare and severe neurological diseases. He is a seasoned biotech and pharma executive with extensive experience building companies, transitioning from R&D to commercialization, and leading successful product launches across oncology, rare disease, gene therapy, radiopharmaceuticals, and targeted therapies in the U.S. and internationally. Carlos previously served as Chief Commercial Officer at Rocket Pharmaceuticals and held senior commercial leadership roles at Novartis and Schering-Plough. He also serves as an independent board member of NKILT Therapeutics.